From researchers to executives, people in the biotechnology industry are always thinking about raising more capital to help fund the endless research and development needed to make technological breakthroughs.
But the sector may have to pay more attention on marketing and branding if it wants to stand out from competitors in the global arena, the head of the semi-official Industrial Technology Research Institute (ITRI) said yesterday at a marketing forum in Taipei.
"Anything that remains local will lose the potential for development," ITRI president Johnsee Lee (李鍾熙) said. "But marketing and networking with international alliances will strengthen our biotech industry."
The forum on marketing for Asian life-science companies was held by BiotechEast Co (東方生技), a Taipei-based public relations and marketing consultancy specializing in the biotech industry.
The firm also signed an agreement with Frost & Sullivan yesterday, making it the sole agent in this country for the New York-based, high-tech market consultancy.
"Taiwan must improve its collaborative efforts with the global life-science community through increased attention to marketing, promotion and networking abroad," BiotechEast president David Silver said.
Marketing and branding is critical to the nation's biotech industry, given the keen competition from regional rivals such as South Korea and Singapore, he said.
Silver said South Korea emphasized its international presence by setting up research units in other countries including the UK, China and Israel in recent years. It also established "Korea BioValley" last year in San Diego, California, the hub of biotechnology, he said.
Singapore places a strong emphasis on overseas promotions, keeps a high profile in international media such as CNN and seeks out international companies for foreign talent, such as ES Cell International, an Australian company that recruited Alan Colman, who became famous for cloning the sheep "Dolly" in 1997.
Taiwan's biotech industry, however, doesn't have enough information available for the international community for those seeking collaboration or investment, said Chen Chei-hsiang (陳啟祥), director of the Biotechnology & Pharmaceutical Industries Program Office (BPIPO) under the Ministry of Economic Affairs.
"We are considering helping the industry promote itself to the world to enhance global visibility," Chen said.
In 2002, the government announced it would promote the biotech industry for the next 10 years, making it one of the key sectors in the "2 Trillion, Twin Star" investment plan. Annual revenues in the industry rose 13 percent to NT$125.6 billion last year from NT$110.9 billion in 2002, according to figures provided by BPIPO.
The government plans to pour NT$150 billion into the sector by 2006, hoping to boost annual revenue to NT$250 billion by 2006.
"The Taiwanese biotech industry has great advantages in terms of government support, strong technological background and robust financial environment to acquire capital," said Aditya Sapru, Frost & Sullivan's director of biotech life science practice in the Asia-Pacific region.
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the